DK0701604T3 - Immortalisering af dendritiske celler med V-myc-onkogenet - Google Patents

Immortalisering af dendritiske celler med V-myc-onkogenet

Info

Publication number
DK0701604T3
DK0701604T3 DK94917670T DK94917670T DK0701604T3 DK 0701604 T3 DK0701604 T3 DK 0701604T3 DK 94917670 T DK94917670 T DK 94917670T DK 94917670 T DK94917670 T DK 94917670T DK 0701604 T3 DK0701604 T3 DK 0701604T3
Authority
DK
Denmark
Prior art keywords
pct
dendritic cells
immortalization
myc oncogene
sec
Prior art date
Application number
DK94917670T
Other languages
English (en)
Inventor
Francesca Granucci
Original Assignee
Biotop S A S Di Rita Cassarin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotop S A S Di Rita Cassarin filed Critical Biotop S A S Di Rita Cassarin
Application granted granted Critical
Publication of DK0701604T3 publication Critical patent/DK0701604T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464452—Transcription factors, e.g. SOX or c-MYC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94917670T 1993-05-31 1994-05-26 Immortalisering af dendritiske celler med V-myc-onkogenet DK0701604T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001118A IT1264516B1 (it) 1993-05-31 1993-05-31 Cellule dendritiche immortalizzate
PCT/EP1994/001720 WO1994028113A1 (en) 1993-05-31 1994-05-26 Immortalization of denditric cells with v-myc oncogene

Publications (1)

Publication Number Publication Date
DK0701604T3 true DK0701604T3 (da) 1999-07-26

Family

ID=11366291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917670T DK0701604T3 (da) 1993-05-31 1994-05-26 Immortalisering af dendritiske celler med V-myc-onkogenet

Country Status (15)

Country Link
US (2) US5856180A (da)
EP (1) EP0701604B1 (da)
JP (1) JP3834059B2 (da)
KR (1) KR100353220B1 (da)
AT (1) ATE173294T1 (da)
AU (1) AU686636B2 (da)
CA (1) CA2164102A1 (da)
DE (1) DE69414572T2 (da)
DK (1) DK0701604T3 (da)
ES (1) ES2126118T3 (da)
GR (1) GR3029374T3 (da)
HU (1) HUT73322A (da)
IT (1) IT1264516B1 (da)
WO (1) WO1994028113A1 (da)
ZA (1) ZA943782B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4337396A1 (de) 1993-10-26 1995-04-27 Beiersdorf Ag Humane Zellinien mit Langerhans-Zell-Charakteristik
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5648248A (en) * 1994-12-30 1997-07-15 Boehringer Ingelheim International Gmbh Methods for producing differentiated cells from immature hematopoietic cells
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses
EP0808364B1 (en) * 1995-02-10 2005-11-30 The Regents of the University of California Human pancreatic cell lines: developments and uses
AU4977896A (en) * 1995-02-17 1996-09-04 Immunotherapy, Inc. Immunotherapy screening, prognosis, and treatment methods and compositions
US5849589A (en) * 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
EP0961824A4 (en) * 1996-07-10 2003-01-29 Immunex Corp DENDRITIC CELL ACTIVATION PROCESS
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
EP1007720B1 (en) 1997-04-15 2008-03-05 Dana Farber Cancer Institute, Inc. Dendritic cell hybrids
US20050169898A1 (en) 1997-04-15 2005-08-04 Jianlin Gong Cell fusions and methods of making and using the same
CA2322660A1 (en) * 1998-03-20 1999-09-23 Genzyme Corporation Enhanced anti-tumor immunity
US7014848B1 (en) 1998-03-20 2006-03-21 Genzyme Corporation Enhanced anti-tumor immunity
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
JP2002509716A (ja) 1998-03-31 2002-04-02 ユニバーシティ テクノロジー コーポレイション テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
US6387888B1 (en) * 1998-09-30 2002-05-14 American Foundation For Biological Research, Inc. Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
JP2004520823A (ja) * 2000-12-13 2004-07-15 イミュネックス・コーポレーション 不死樹状細胞系の作製方法
US7704964B2 (en) 2001-08-17 2010-04-27 Exothera L.L.C. Methods and compounds for the targeting of protein to exosomes
US8095735B2 (en) 2008-08-05 2012-01-10 Convey Computer Memory interleave for heterogeneous computing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5648248A (en) * 1994-12-30 1997-07-15 Boehringer Ingelheim International Gmbh Methods for producing differentiated cells from immature hematopoietic cells

Also Published As

Publication number Publication date
GR3029374T3 (en) 1999-05-28
EP0701604A1 (en) 1996-03-20
ATE173294T1 (de) 1998-11-15
CA2164102A1 (en) 1994-12-08
DE69414572D1 (de) 1998-12-17
JPH09500523A (ja) 1997-01-21
ZA943782B (en) 1995-02-09
AU6929994A (en) 1994-12-20
ES2126118T3 (es) 1999-03-16
HU9503414D0 (en) 1996-01-29
EP0701604B1 (en) 1998-11-11
US5856180A (en) 1999-01-05
US6156307A (en) 2000-12-05
JP3834059B2 (ja) 2006-10-18
WO1994028113A1 (en) 1994-12-08
ITMI931118A1 (it) 1994-12-01
IT1264516B1 (it) 1996-09-24
ITMI931118A0 (it) 1993-05-31
KR100353220B1 (ko) 2003-12-31
HUT73322A (en) 1996-07-29
DE69414572T2 (de) 1999-07-29
AU686636B2 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
PT716689E (pt) Processo para a preparacao e cultura de celulas progenitoras hematopoieticas
ES2146611T3 (es) Tejido cartilaginoso reconstituido.
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
BR9803807A (pt) Processo para produção de protéina.
PT789588E (pt) Processo para a producao de um medicamento para o tratamento de imunodeficiencia secundaria
DE69126526D1 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
WO1996002877A3 (en) Method and system for automatic compensation of line delay in a clock distribution system
ATE112239T1 (de) Vaterit und verfahren zu dessen herstellung.
DK0868437T3 (da) Fremgangsmåde til fremstilling af hyaluronsyrefraktion med et lavt polydispersionsindeks
ES2095738T3 (es) Procedimiento de fabricacion para objeto portador de mensaje.
SI1456238T1 (sl) Proizvodnja f(ab)2 fragmentov v sesalskih celicah
DE69333547D1 (de) Therapeutische anwendungen von chimänischer organogenese
ES2160829T3 (es) Procedimiento para la obtencion de riboflavina por medio de microorganismos con actividad de isocitratoliasa modificada.
Griffin Synchronization of some human cell strains by serum and calcium starvation
CA2151123A1 (fr) Cellules modifiees au niveau du catabolisme de la betaine, preparation et utilisations, notamment pour la production de metabolites ou d'enzymes
BR0008536A (pt) Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro
EP1270719A3 (en) Cell population containing non-fetal hemangioblasts and method for producing same
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
Chotard‐Ghodsnia et al. Cyclic AMP‐dependent cell shape changes induced by mechanical forces
ES2106361T3 (es) Procedimiento para la modificacion de polimeros.
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens
DK0680467T3 (da) Fremgangsmåde til fremstilling af C-substituerede diethylentriaminer